In 2002, Real et al. described resistance to chemotherapy via overexpression of the anti-apoptotic protein Bcl-2 in metastatic breast cancer cells, which correlated with the activation of the STAT3 pathway [38]. This evidence concerns the gene BCL2 and breast carcinoma.